We have located links that may give you full text access.
Journal Article
Review
Comparison of early postoperative results between robot-assisted and laparoscopic splenectomy for non-traumatic splenic diseases rather than portal hypertensive hypersplenism-a meta-analysis.
Asian Journal of Surgery 2019 July 24
Laparoscopic splenectomy (LS) is considered as the gold standard in the surgical management of non-traumatic diseases of spleen (NDOS), and robotic splenectomy (RS) is a promising alternative treatment. This study aimed to compare the effectiveness and safety of RS versus LS for NDOS. Several databases were systematically searched for the literature that compared RS with LS for NDOS. Primary outcomes included operative time, blood loss, conversion to open, hospital stay, cost, postoperative complication, and postoperative morbidity. Study-specific effect sizes and their 95% confidence interval (CI) were combined to calculate the pooled value using a fixed-effects or random-effects model. Seven studies were included with 374 patients. Major blood loss (mean difference [MD] = -127.14; 95% CI = -199.87-54.42), conversion to open (rate difference [RD] = -0.06; 95% CI = -0.11-0.01), and postoperative complication (RD = -0.10; 95% CI = -0.20-0.01) were less in the RS group compared with the LS group. There were no differences found in operative time and hospital stay. In our meta-analysis, perioperative mortality was not observed in the RS group. Compared with the LS group, RS group showed comparable effectiveness and safety for the treatment of NDOS based on the current evidence.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app